Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mmm.2021.02.013 http://scihub22266oqcxt.onion/10.1016/j.mmm.2021.02.013 C7904517/?report=reader!7904517!C7904517     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ä-/-ä 2021 ; 15 (3): 278-87 Nephropedia Template TP {{tp|p=C7904517|t=2021. La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19 |pdf=|usr=}}{{C7904517}} gab.com Text La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19 JO: ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=C7904517 #FOAvip Metformin exerts anti-inflammatory and immunosuppressive effects. We addressed the impact of prior metformin use on the prognosis of patients with type 2 diabetes hospitalised for COVID-19. We used data from the nationwide observational CORONADO cohort that included patients with diabetes hospitalised for COVID-19 between March 10 and April 10, 2020 in 68 French centres. The primary outcome was combined tracheal intubation and/or death within 7 days of admission. A Kaplan?Meier survival curve was reported for death up to day 28. The association between metformin use and outcomes was then estimated in a logistic regression analysis after applying propensity score weighting approach to account for treatment allocation. Among the 2449 patients included, 1496 were metformin users and 953 were not. Compared with non-users, metformin users were younger with a lower prevalence of diabetic complications, but had more severe features of COVID-19 at admission. The most striking feature was a lower mortality rate in metformin users vs. non-users on day 7 (8.2 % vs. 16.1 %, respectively; P < 0.0001) and on day 28 (16.0 % vs. 28.6 %, respectively: P < 0.0001), even after propensity score weighting was applied. Randomised, controlled studies are now needed in order to confirm the benefits associated with metformin and to establish to what extent these protective effects, if any, can be generalised to non-diabetic patients with COVID-19. Twit Text FOAVip La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19 ????ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=C7904517 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=C7904517 #FOAvip English Wikipedia <ref>{{Cite pmid|C7904517}}</ref> La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19 #MMPMIDC7904517 Lalau JD; Al-Salameh A; Wiernsperger N; Goronflot T; Pichelin M; Wargny M; Desailloud R; Hadjad S; Gourdy P; Cariou B ä-/-ä 2021[May]; 15 (3): 278-87 PMIDC7904517show ga Metformin exerts anti-inflammatory and immunosuppressive effects. We addressed the impact of prior metformin use on the prognosis of patients with type 2 diabetes hospitalised for COVID-19. We used data from the nationwide observational CORONADO cohort that included patients with diabetes hospitalised for COVID-19 between March 10 and April 10, 2020 in 68 French centres. The primary outcome was combined tracheal intubation and/or death within 7 days of admission. A Kaplan?Meier survival curve was reported for death up to day 28. The association between metformin use and outcomes was then estimated in a logistic regression analysis after applying propensity score weighting approach to account for treatment allocation. Among the 2449 patients included, 1496 were metformin users and 953 were not. Compared with non-users, metformin users were younger with a lower prevalence of diabetic complications, but had more severe features of COVID-19 at admission. The most striking feature was a lower mortality rate in metformin users vs. non-users on day 7 (8.2 % vs. 16.1 %, respectively; P < 0.0001) and on day 28 (16.0 % vs. 28.6 %, respectively: P < 0.0001), even after propensity score weighting was applied. Randomised, controlled studies are now needed in order to confirm the benefits associated with metformin and to establish to what extent these protective effects, if any, can be generalised to non-diabetic patients with COVID-19. äLa metformine est associée à une moindre mortalité chez les patients d(epmc).pdf DeepDyve Pubget Overpricing